Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chikungunya vaccine
- Development stage
- Preclinical
- Lead developer
- Gamma Vaccines
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Chikungunya vaccine is a preclinical prophylactic vaccine candidate being developed by Gamma Vaccines for prevention of chikungunya. It is described on the company pipeline as a licensed vaccine and, based on Gamma Vaccines' platform description and the provided context, is intended to induce protective immune responses against chikungunya virus using a photon inactivation or gamma-irradiation based vaccine approach, although the exact public modality details remain limited. The program is under exclusive worldwide license from Griffith University and is being advanced within Gamma Vaccines' vaccine platform for mosquito-borne viral disease prevention.
- Other names
- chikungunya vaccineChikungunya vaccine licensed
02
Targets
CHIKV E2/E1 (Chikungunya virus envelope protein)
Beyond the preview
Go deeper on Chikungunya vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chikungunya vaccine.